Literature DB >> 15951179

Modulation of lung epithelial functions by Pseudomonas aeruginosa.

Gee W Lau1, Daniel J Hassett, Bradley E Britigan.   

Abstract

Microorganisms gain access to the airways and respiratory epithelial surface during normal breathing. Most inhaled microbes are trapped on the mucous layer coating the nasal epithelium and upper respiratory tract, and are cleared by ciliary motion. Microorganisms reaching the alveolar spaces are deposited on the pulmonary epithelium. This contact initiates complex offensive and defensive strategies by both parties. Here, we briefly outline how the pulmonary pathogen Pseudomonas aeruginosa uses multi-pronged strategies that include cell surface appendages, and secreted and injected virulence determinants to switch from an unobtrusive soil bacterium to a pathogen for lung epithelium colonization. Understanding the complex interactions between the lung epithelium and P. aeruginosa might enable more effective therapeutic strategies against infection in cystic fibrosis and immuno-compromised individuals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951179     DOI: 10.1016/j.tim.2005.05.011

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  49 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing.

Authors:  Zhizhou Kuang; Yonghua Hao; Sunghei Hwang; Shiping Zhang; Eunice Kim; Henry T Akinbi; Michael J Schurr; Randall T Irvin; Daniel J Hassett; Gee W Lau
Journal:  Mol Microbiol       Date:  2011-01-06       Impact factor: 3.501

3.  Nucleoside diphosphate kinase and flagellin from Pseudomonas aeruginosa induce interleukin 1 expression via the Akt/NF-κB signaling pathways.

Authors:  Yong-Jae Kim; Jung-Hoon Lee; Yeji Lee; Jingyue Jia; Se-Hwan Paek; Hyong-Bai Kim; Shouguang Jin; Un-Hwan Ha
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

4.  Ligand responses of Vfr, the virulence factor regulator from Pseudomonas aeruginosa.

Authors:  Jose Serate; Gary P Roberts; Otto Berg; Hwan Youn
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

Review 5.  Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung.

Authors:  Alicia E Ballok; George A O'Toole
Journal:  J Bacteriol       Date:  2013-07-08       Impact factor: 3.490

6.  A Novel Depsipeptide Produced by Paenibacillus alvei 32 Isolated from a Cystic fibrosis Patient.

Authors:  Romain Chevrot; Sandrine Didelot; Larissa Van den Bossche; Fatoumata Tambadou; Thibault Caradec; Pierre Marchand; Esther Izquierdo; Valérie Sopéna; Jocelyne Caillon; Cyrille Barthélémy; Ann Van Schepdael; Jos Hoogmartens; Eric Rosenfeld
Journal:  Probiotics Antimicrob Proteins       Date:  2013-03       Impact factor: 4.609

7.  Cif is negatively regulated by the TetR family repressor CifR.

Authors:  Daniel P MacEachran; Bruce A Stanton; George A O'Toole
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

8.  Characterization of hydrogen peroxide production by Duox in bronchial epithelial cells exposed to Pseudomonas aeruginosa.

Authors:  Balázs Rada; Thomas L Leto
Journal:  FEBS Lett       Date:  2010-01-19       Impact factor: 4.124

Review 9.  Bench-to-bedside review: Bacterial virulence and subversion of host defences.

Authors:  Steven A R Webb; Charlene M Kahler
Journal:  Crit Care       Date:  2008-11-10       Impact factor: 9.097

10.  Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells.

Authors:  Eloïse Raoust; Viviane Balloy; Ignacio Garcia-Verdugo; Lhousseine Touqui; Reuben Ramphal; Michel Chignard
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.